HCPCS Level IIdrugActive

J9381

Inj teplizumab mzwv 5 mcg

BETOS: O1E

Effective: 2023-07-01

Referenced in 1 policies

Description

Injection, teplizumab-mzwv, 5 mcg

Medicare Part B Drug Pricing

Average Sales Price (ASP) data for Q1 2026

Drug Name

Tzield

Manufacturer

Provention Bio, Inc.

HCPCS Dosage

5 MCG

Billing Units

400.0000

NDC Products

asp

Pricing Source

Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.